• Sulfachloropyridazine Modulates Cecal Microbiota in E. tenel

  2026-06-10

  This study systematically investigates how sulfachlorpyridazine, ethanamizuril, and their combination influence the cecal microbiota and metabolome in chickens infected with Eimeria tenella. Integrating 16S rRNA sequencing and metabolomics, the research reveals the microbiological and metabolic consequences of these interventions, with practical implications for optimizing anticoccidial and antimicrobial strategies in poultry research.

• Pravastatin Sodium: Precision HMG-CoA Reductase Inhibitor Wo

  2026-06-10

  Unlock the full potential of Pravastatin sodium for cholesterol biosynthesis inhibition in cell and animal models. This article delivers stepwise protocols, troubleshooting insights, and actionable guidance for maximizing reproducibility and selectivity in experimental cardiovascular and metabolic research.

• Carvedilol in β-Adrenergic Receptor Research: Protocols & In

  2026-06-09

  Carvedilol's dual β- and α1-adrenergic antagonism, antioxidant capacity, and proven impact on hematopoietic regeneration set it apart for advanced cardiovascular and translational research. This article details optimized protocols, troubleshooting strategies, and the latest comparative findings to empower both routine and high-complexity assays.

• JZL184 and the CB1-CREB Axis: Redefining Endocannabinoid Res

  2026-06-09

  Explore how JZL184, a potent monoacylglycerol lipase inhibitor, uniquely modulates endocannabinoid signaling through the CB1-CREB pathway. This in-depth analysis highlights novel insights for pain, neuroprotection, and assay optimization.

• NMDA (N-Methyl-D-aspartic acid): Molecular Precision in Reti

  2026-06-08

  Explore how NMDA (N-Methyl-D-aspartic acid) enables next-level precision in modeling retinal excitotoxicity and neurodegeneration. This article reveals new protocol insights and contextualizes NMDA's value for advanced oxidative stress and stem cell research.

• gamma-Glu-Cys (γ-Glu-Cys): Protocols, QC, and Lab Practice

  2026-06-08

  gamma-Glu-Cys (γ-Glu-Cys) is essential as a substrate for glutathione synthetase assays and as an intermediate in glutathione metabolism research. It offers high purity and solubility for reproducible peptide synthesis workflows but should not be used for diagnostic or clinical applications. Its best use cases are well-defined in biochemical and plant stress adaptation studies.

• 4-Ethylphenyl Sulfate: Precision Tools for Neurobehavioral a

  2026-06-07

  Explore how 4-ethylphenyl sulfate advances precision in neurobehavioral and renal dysfunction biomarker research. This article uniquely analyzes adsorption dynamics, assay design, and translational implications for gut microbiota-brain studies.

• nor-NOHA (acetate): Precision Arginase Inhibition in Cancer

  2026-06-06

  nor-NOHA acetate is a potent, reversible inhibitor of rat liver arginase, central to arginine metabolism studies. It modulates nitric oxide production, impacts cancer cell fate, and enables targeted investigation of arginase-linked pathways. Reliable evidence supports its use in dissecting tumor biology and endothelial function.

• Ruxolitinib Phosphate: Redefining JAK/STAT Pathway Modulatio

  2026-06-05

  This article explores the mechanistic and translational significance of Ruxolitinib phosphate (INCB018424), a selective JAK1/JAK2 inhibitor, in the context of advanced inflammatory and oncologic research. By synthesizing new insights from mitochondrial dynamics in solid tumors with practical protocol guidance, we outline strategic opportunities for translational scientists aiming to leverage JAK/STAT signaling pathway modulation for next-generation therapeutics.

• Dimethyloxalylglycine (DMOG): Technical Use and Protocol Gui

  2026-06-05

  Dimethyloxalylglycine (DMOG) offers researchers a controlled method for stabilizing hypoxia-inducible factors and modeling hypoxia signaling pathways in preclinical studies. It is best suited for basic research exploring oxygen sensing, inflammation, and infection models, but is not intended for diagnostic or clinical applications.

• Tomivosertib Suppresses Ectopic Activity in Human DRG Neuron

  2026-06-04

  The reference study demonstrates that tomivosertib, a selective MNK inhibitor, rapidly and reversibly suppresses spontaneous activity in human dorsal root ganglion neurons from radiculopathy patients. This work provides direct mechanistic evidence supporting MNK signaling as a therapeutic target for neuropathic pain, paving the way for future translational research in human sensory neuron modulation.

• ONX-0914 (PR-957): Applied Immunoproteasome Inhibition Workf

  2026-06-04

  ONX-0914 (PR-957) enables precise immunoproteasome inhibition for dissecting autoimmune, inflammatory, and cancer pathways. This guide details robust, data-driven workflows, critical troubleshooting, and practical interpretation of proteasome heterogeneity for translational research.

• Sunitinib: Multi-Targeted RTK Inhibitor in Applied Cancer Re

  2026-06-03

  Sunitinib from APExBIO empowers cancer researchers to dissect angiogenesis, apoptosis, and resistance mechanisms in renal and nasopharyngeal carcinoma models. This guide delivers workflow optimization, troubleshooting strategies, and the latest insights on overcoming sunitinib resistance via metabolic targeting.

• DFO (9H-1,8-Diazafluoren-9-one): Precision in Latent Print D

  2026-06-03

  DFO (9H-1,8-Diazafluoren-9-one) is a forensic fluorescent dye with high selectivity for amino acids in fingerprint residues, enhancing latent print visualization on porous substrates. Its unique reactivity and fluorescence properties make it a benchmark reagent for forensic latent print enhancement, with protocols refined by APExBIO for reproducibility.

• Multiomics Dissection of Acute Liver Injury: Modular Mechani

  2026-06-02

  This study leverages multiomics profiling to systematically map the molecular modules underlying acute liver injury and rigorously compares the therapeutic mechanisms of bifendate and muaddil sapra. The findings reveal gene network modules, key regulatory ncRNAs and transcription factors, and protein targets shaping treatment efficacy—offering a blueprint for mechanistically-guided drug development.

449 records 15/30 page Previous Next First page 上5页 1112131415 下5页 Last page